U.S. Healthcare Services Stock News

Thinking about making a move with Ferguson Enterprises? You are not alone. With shares recently closing at $232.49, Ferguson has been quietly making waves while many investors debate whether the stock is now a buy, a hold, or due for a breather. Over the past year, it has gained 9.7%, which is not a headline-grabbing surge but steady enough to catch the eye. Even more compelling, the stock is up 34.1% year-to-date and a substantial 110.1% over three years, reflecting solid long-term momentum...

If you’ve been watching CoreWeave (CRWV) lately, the stock’s recent move probably caught your attention. There wasn’t a single headline-driving event or massive product announcement, yet shares have moved enough in the past month to stir debate among investors. Sometimes shifts like this are just noise, but they can also signal changing expectations beneath the surface. That is always worth a closer look. Looking at the past year, CoreWeave’s shares have rallied more than 130%, even with a...

Thinking about what to do with TransDigm Group stock right now? You are not alone. With its share price closing last at $1,389.98 and recent moves catching more than a few eyes, it is natural to wonder whether it is time to buy in, take profits, or simply watch from the sidelines. Over the past week, shares slipped by 0.6%, and the 30-day window shows a deeper dip of 13.5%. Looking further back, the numbers tell a different story: up 10.8% year to date, 10.7% over the last year, and an...

If you have Danaher on your watchlist, you are not alone in wondering whether now is the right moment to act. The past year has been a wild ride for the stock, dragging it down by 22.3% over twelve months and by 9.6% year-to-date. Even with a modest uptick of 1.1% in the last month, Danaher still has not fully shaken concerns about shifting market sentiment and broader volatility in health sciences and industrial technology sectors. Looking further back, the five-year return of 14.8% serves...

If you have been eyeing AT&T and wondering whether now is the right time to make a move, you are not alone. The market has been watching closely as this telecom giant’s stock steadily climbed, with AT&T delivering a 53.1% gain over the past year and 25.9% just since the start of this year. Even after a minor dip of -0.8% in the past week, the long-term chart hints at real staying power, topped off by a 92.2% three-year return. That kind of outperformance inevitably sparks debates about...

If you are wondering whether Uranium Energy deserves a spot in your portfolio, you are not alone. With uranium prices grabbing global headlines and investors seeking exposure to clean energy sources, Uranium Energy’s stock has caught quite a few eyes. Over the last year alone, shares have skyrocketed by a staggering 96.2%. Even when you zoom out to the last five years, the stock has climbed an incredible 804.3%, handily outperforming many peers. Of course, no stock moves in a straight line...

Mueller Industries, Inc. ( NYSE:MLI ) saw a significant share price rise of 30% in the past couple of months on the...

Cboe Global Markets recently announced a 14% increase in its quarterly dividend and named Prashant Bhatia as Executive Vice President, Head of Enterprise Strategy & Corporate Development, effective September 2, 2025. Bhatia brings more than 30 years of global financial services experience and a strong track record in corporate development, signaling increased emphasis on long-term growth initiatives. We'll examine how the substantial dividend hike signals management's confidence in Cboe's...

Thinking about what to do with Amgen stock lately? You are not alone. With biotech making headlines and market sentiment shifting, a lot of investors are weighing their next move. Looking over the past year, Amgen has seen some ups and downs: the stock is down 1.4% this week, off 5.9% for the month, but still up a healthy 11.3% since January. If you zoom out even farther, its 3- and 5-year performances show gains of 32.6% and 33.2%, respectively, although it is off by 8.8% compared to this...

If you are wondering what to do with Kenvue stock after its recent trading swings, you are not alone. Many investors are weighing whether the dip in price is an opportunity, a warning, or just another chapter in this company’s story. Kenvue’s shares recently closed at $21.19, down 1.4% over the past week and 7.2% across the last 30 days, while staying nearly flat for the year so far. The stock’s modest 0.3% gain over the past year hints at resilience, but also raises eyebrows for those...

Premier, Inc. recently reported its fourth quarter and full-year 2025 earnings, revealing lower revenues of US$262.86 million for the quarter and US$1.01 billion for the year, alongside reduced net income and earnings per share compared to the previous year. Alongside weaker results and cautious 2026 revenue guidance, Premier highlighted ongoing share repurchases, a steady dividend, and new plans to pursue tuck-in acquisitions to strengthen its core offerings. We'll explore how Premier's...

On August 12, 2025, Pharvaris N.V. reported its second quarter and six-month financial results, revealing a net loss of €45.48 million and €91.82 million, respectively, both higher than the same periods last year. The company’s losses per share from continuing operations also increased significantly year-over-year, indicating ongoing financial pressures. With widening losses driving recent earnings headlines, we’ll explore how this shapes Pharvaris’s investment narrative amid persistent cost...

Despite an already strong run, Twin Disc, Incorporated ( NASDAQ:TWIN ) shares have been powering on, with a gain of 40...

If you are wondering what to do with HubSpot stock right now, you are in good company. Investors have been on a wild ride lately, with the stock climbing 4.4% over the past week, yet still sitting nearly 33% lower year-to-date. That kind of volatility can stir up lots of questions, especially when you realize that just in the last five years, HubSpot has delivered returns over 56%. Clearly, the story here is more complex than a single quarter or market shift. Part of that story comes down to...

Thinking about what to do with Constellation Energy stock? You are not alone. With so much movement in the market, it can be tough to know when to sit tight and when to take action. Lately, Constellation Energy has given investors a lot to talk about. Over the last week, the stock dipped 3.7%, and in the past month, it slid by 5.1%. If you zoom out, the story becomes more interesting. Shares are still up a notable 28.1% year-to-date, and an impressive 60.4% over the past 12 months. Looking...

Thinking about what to do with Biogen stock right now? You are not alone. There's a lot of debate swirling around this biotech giant, especially as its shares have been through quite the journey over the past few years. Some investors have been disappointed by the slide—down over 33.4% in the past year and more than 50% in the last five years—while others are starting to pay attention to signs that sentiment could be shifting. Over the last week, Biogen stock crept up a modest 0.3%, with a...

Matador Resources recently reported record quarterly production for fiscal Q2 2025 and highlighted its strong balance sheet, with over US$1.8 billion in liquidity and a leverage ratio below 1.0x as of June 30. This financial and operational update underscores the company’s ongoing focus on production growth and fiscal discipline amid evolving industry conditions. We’ll explore how Matador’s record production performance in Q2 2025 could influence its future investment narrative and strategic...

If you have been following Webull lately, you probably noticed the buzz in the investment community. Many investors are watching closely, trying to decide whether to double down or take profits now that the stock has had such a dynamic ride. Webull's story is hard to ignore. After climbing an impressive 28.7% since the start of the year and delivering a strong 33.3% gain over the past twelve months, expectations are running high. Despite those impressive long-term returns, the last month has...

Most readers would already be aware that Cabot's (NYSE:CBT) stock increased significantly by 7.1% over the past month...

If you are looking at TJX Companies and wondering if now is the right moment to buy, hold, or rethink your position, you are not alone. The stock has been quietly rewarding patient shareholders for years, with the last five years bringing a powerful 165.6% return and an impressive 124.1% jump over three years. Even in the past month, TJX has gained 7.2%, and year-to-date it is up 11.8%. Despite some ongoing changes in consumer behavior and broader market developments, investor sentiment for...

If you are weighing what to do about Royal Caribbean Cruises stock right now, you are not alone. The share price has been a livewire, delivering a 106.3% jump over the past year and a remarkable 735.6% over the last three years, making those pandemic-era lows seem like ancient history. Even in the short term, Royal Caribbean is still riding some waves, up 4.5% in the last week but down 2.2% over the past month, as investors digest changing market sentiment and industry headlines. Momentum...

Despite an already strong run, Perimeter Solutions, Inc. ( NYSE:PRM ) shares have been powering on, with a gain of 26...

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

If you have been watching 3M lately and wondering whether now is the right time to make a move with its stock, you are in good company. The share price has picked up some positive momentum, rising 1.0% over the past week and 3.0% over the last month. Even more impressive, the stock is currently 20.2% higher so far this year, and it is up a solid 21.0% over the past twelve months. These numbers certainly catch the eye, especially for anyone who remembers 3M’s challenges in previous years. With...